These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35781)

  • 1. Central action of narcotic analgesics. Part IV. Noradrenergic influences on the activity of analgesics in rats.
    Malec D; Grabowska E; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(5):627-37. PubMed ID: 35781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D; Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central action of narcotic analgesics. VI. Further studies on the participation of serotonin in the action of analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1980; 32(5):665-72. PubMed ID: 6115369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic influences on opioids activity in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):85-92. PubMed ID: 6891961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central action of narcotic analgesics. II. Locomotor activity and narcotic analgesics.
    Fidecka S; Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(1):5-16. PubMed ID: 25426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central action of narcotic analgesics. Part III. The role of endogenous noradrenaline in hyperactivity induced by morphine or fentanyl in mice.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(4):537-47. PubMed ID: 216979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of benzodiazepines on the central action of narcotic analgesics.
    Matla J; Langwiński R
    Pol J Pharmacol Pharm; 1982; 34(1-3):135-44. PubMed ID: 6132369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of 5-HT receptor blocking agents on the behavioral effects of analgesics in rats.
    Malec D; Langwiński R
    Psychopharmacology (Berl); 1980; 69(1):79-83. PubMed ID: 6771831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
    Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM).
    Rendig SV; Amsterdam EA; Henderson GL; Mason DT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):259-65. PubMed ID: 6109016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
    Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
    J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
    Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
    Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
    Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
    Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.